Related Experiment Video
Updated: Mar 9, 2026
09:34
Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
34.9K
Cytotoxic T lymphocyte-associated antigen 4 rs231775 polymorphism and osteosarcoma
Neoplasma
|January 6, 2017
Summary
The CTLA4 rs231775 AA genotype is linked to osteosarcoma risk in the Spanish population. This finding, consistent across populations, suggests rs231775 as a potential osteosarcoma susceptibility marker.
Area of Science:
- Genetics
- Oncology
- Immunology
Background:
- Previous studies identified a link between CTLA4 rs231775 AA genotype and osteosarcoma risk in Chinese populations.
- The rs231775 single nucleotide polymorphism (SNP) exhibits varying frequencies across different human populations.
- Investigating this SNP in other populations is crucial for understanding its broader role in osteosarcoma susceptibility.
Purpose of the Study:
- To evaluate the association between the CTLA4 rs231775 polymorphism and osteosarcoma susceptibility in the Spanish population.
- To conduct an updated meta-analysis to consolidate findings on rs231775 and osteosarcoma risk across diverse populations.
Main Methods:
- Genotypic association analyses were performed on data from 538 osteosarcoma cases and 623 controls from the Spanish population.
- An updated meta-analysis was conducted to synthesize evidence from multiple studies.
- Statistical analysis focused on the CTLA4 rs231775 (+49A/G) polymorphism and its association with osteosarcoma risk.
Main Results:
- Genotypic association analyses revealed that the CTLA4 rs231775 polymorphism is associated with osteosarcoma susceptibility in the Spanish population.
- The meta-analysis demonstrated that the CTLA4 rs231775 AA genotype is significantly associated with an increased risk of developing osteosarcoma across all analyzed populations (OR=2.07; 95% CI: 1.48-2.89).
Conclusions:
- The CTLA4 rs231775 AA genotype is a significant risk factor for osteosarcoma in the Spanish population.
- The rs231775 AA genotype may serve as a valuable susceptibility marker for osteosarcoma.
- Further research is warranted to explore the functional mechanisms underlying this association.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
60
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
60
02:41Lethal Alleles
18.7K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
18.7K
01:32RNA Splicing
61.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.0K
01:31Translation
21.1K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
21.1K